Agios Pharma Financial Overview
Agios Pharma's market cap is currently $1.52B. The company's EPS TTM is $-1.78; its P/E ratio is ―; Agios Pharma is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-1.95. See an overview of income statement, balance sheet, and cash flow financials.
